Ikarian Capital
Latest statistics and disclosures from Ikarian Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARGX, KRYS, CYTK, ALNY, XBI, and represent 28.37% of Ikarian Capital's stock portfolio.
- Added to shares of these 10 stocks: ARGX (+$86M), KRYS (+$63M), CYTK (+$53M), ALNY (+$51M), XBI (+$49M), CRSP (+$43M), LLY (+$40M), SRPT (+$40M), PRTA (+$37M), AMLX (+$32M).
- Started 26 new stock positions in MOR, XHB, Karuna Therapeutics Ord, ALPN, RPHM, ARGX, CORT, ANVS, Icosavax, FUSN.
- Reduced shares in these 10 stocks: , QQQ (-$43M), REPL (-$13M), AKRO (-$10M), , RCKT (-$8.0M), PCVX (-$7.3M), RARE (-$6.2M), IDYA (-$5.9M), Ambrx Biopharma (-$5.7M).
- Sold out of its positions in AKRO, Ambrx Biopharma, BMRN, BIVI, COGT, Cymabay Therapeutics, ETNB, Phaxiam Therapeutics S A, FGEN, FHTX.
- Ikarian Capital was a net buyer of stock by $601M.
- Ikarian Capital has $1.1B in assets under management (AUM), dropping by 63.57%.
- Central Index Key (CIK): 0001778253
Tip: Access up to 7 years of quarterly data
Positions held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ikarian Capital
Ikarian Capital holds 101 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 8.0 | $86M | NEW | 226k | 379.12 |
|
| Krystal Biotech Call Option (KRYS) | 5.9 | $64M | +60491% | 512k | 124.06 |
|
| Cytokinetics Com New (CYTK) | 5.0 | $53M | +15551% | 637k | 83.49 |
|
| Alnylam Pharmaceuticals Call Option (ALNY) | 4.8 | $51M | NEW | 268k | 191.41 |
|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 4.6 | $49M | +10900% | 550k | 89.29 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 4.2 | $45M | +2118% | 724k | 62.60 |
|
| Eli Lilly & Co. Put Option (LLY) | 3.8 | $41M | +5604% | 70k | 582.92 |
|
| Sarepta Therapeutics (SRPT) | 3.8 | $40M | +7095% | 417k | 96.43 |
|
| Prothena Corp SHS Call Option (PRTA) | 3.5 | $37M | NEW | 1.0M | 36.34 |
|
| Amylyx Pharmaceuticals (AMLX) | 3.0 | $32M | +105270% | 2.2M | 14.72 |
|
| Nuvalent Inc-a (NUVL) | 2.8 | $30M | +46% | 411k | 73.59 |
|
| Immunovant (IMVT) | 2.8 | $29M | +125% | 699k | 42.13 |
|
| Crinetics Pharmaceuticals In (CRNX) | 2.6 | $28M | -2% | 780k | 35.58 |
|
| Soleno Therapeutics (SLNO) | 2.3 | $25M | +13% | 611k | 40.25 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 2.3 | $24M | +23129% | 1.0M | 23.11 |
|
| Abbvie Call Option (ABBV) | 1.9 | $21M | +9900% | 133k | 154.97 |
|
| Spdr Ser Tr S&p Homebuild (XHB) | 1.8 | $19M | NEW | 200k | 95.66 |
|
| Bridgebio Pharma (BBIO) | 1.8 | $19M | 473k | 40.37 |
|
|
| Biomea Fusion Call Option (BMEA) | 1.7 | $19M | NEW | 1.3M | 14.52 |
|
| Karuna Therapeutics Ord Call Option | 1.7 | $19M | NEW | 59k | 316.51 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.7 | $18M | NEW | 285k | 62.00 |
|
| Corcept Therapeutics Incorporated Call Option (CORT) | 1.7 | $18M | NEW | 543k | 32.48 |
|
| Acelyrin (SLRN) | 1.6 | $17M | -20% | 2.3M | 7.46 |
|
| ImmunoGen | 1.5 | $16M | +38% | 547k | 29.65 |
|
| Dyne Therapeutics (DYN) | 1.4 | $15M | +41847% | 1.1M | 13.30 |
|
| Tarsus Pharmaceuticals (TARS) | 1.2 | $13M | +19% | 619k | 20.25 |
|
| Moonlake Immunotherapeutics Class A Ord Put Option (MLTX) | 1.1 | $12M | NEW | 201k | 60.39 |
|
| Annexon (ANNX) | 1.1 | $12M | NEW | 2.7M | 4.54 |
|
| Rocket Pharmaceuticals (RCKT) | 1.1 | $12M | -40% | 390k | 29.97 |
|
| Disc Medicine (IRON) | 1.1 | $11M | +34% | 195k | 57.76 |
|
| Apellis Pharmaceuticals (APLS) | 1.0 | $11M | +6538% | 184k | 59.86 |
|
| Amgen Call Option (AMGN) | 0.9 | $10M | NEW | 35k | 288.02 |
|
| Cabaletta Bio (CABA) | 0.9 | $9.5M | NEW | 417k | 22.70 |
|
| Alexandria Real Estate Equities Put Option (ARE) | 0.9 | $9.3M | NEW | 73k | 126.77 |
|
| Alpine Immune Sciences (ALPN) | 0.9 | $9.3M | NEW | 487k | 19.06 |
|
| Catalyst Pharmaceutical Partners (CPRX) | 0.8 | $8.5M | 506k | 16.81 |
|
|
| Marinus Pharmaceuticals Com New (MRNS) | 0.8 | $8.1M | 746k | 10.87 |
|
|
| Novavax Com New Call Option (NVAX) | 0.7 | $7.8M | +8342% | 1.6M | 4.80 |
|
| Arcus Biosciences Incorporated Call Option (RCUS) | 0.7 | $7.6M | +54% | 400k | 19.10 |
|
| Protagonist Therapeutics (PTGX) | 0.7 | $7.3M | NEW | 319k | 22.93 |
|
| Xenon Pharmaceuticals Put Option (XENE) | 0.7 | $7.1M | +1400709% | 154k | 46.06 |
|
| Icosavax | 0.6 | $6.9M | NEW | 440k | 15.76 |
|
| Moderna (MRNA) | 0.6 | $6.8M | +2718% | 69k | 99.45 |
|
| Lyra Therapeutics (LYRA) | 0.6 | $6.6M | 1.3M | 5.24 |
|
|
| Longboard Pharmaceuticals In (LBPH) | 0.6 | $5.9M | +90% | 980k | 6.03 |
|
| Jazz Pharmaceuticals Shs Usd Call Option (JAZZ) | 0.5 | $5.1M | +9900% | 42k | 123.00 |
|
| Fusion Pharmaceuticals (FUSN) | 0.4 | $4.8M | NEW | 500k | 9.61 |
|
| Praxis Precision Medicines I Com New (PRAX) | 0.4 | $4.5M | NEW | 200k | 22.28 |
|
| Morphosys Sponsored Ads Call Option (MOR) | 0.4 | $4.0M | NEW | 400k | 9.90 |
|
| Iteos Therapeutics (ITOS) | 0.4 | $3.8M | 347k | 10.95 |
|
|
| Reneo Pharmaceuticals (RPHM) | 0.3 | $3.1M | NEW | 1.9M | 1.60 |
|
| Abeona Therapeutics Com New (ABEO) | 0.3 | $3.0M | NEW | 600k | 5.01 |
|
| Edgewise Therapeutics (EWTX) | 0.3 | $3.0M | NEW | 270k | 10.94 |
|
| Astria Therapeutics (ATXS) | 0.3 | $2.9M | 375k | 7.68 |
|
|
| Larimar Therapeutics (LRMR) | 0.3 | $2.7M | -11% | 603k | 4.55 |
|
| Voyager Therapeutics (VYGR) | 0.2 | $2.6M | 306k | 8.44 |
|
|
| Mind Medicine Mindmed Com New (MNMD) | 0.2 | $2.2M | NEW | 600k | 3.66 |
|
| Aeon Biopharma Cl A (AEON) | 0.2 | $1.9M | 258k | 7.20 |
|
|
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $1.8M | 1.2M | 1.51 |
|
|
| Roivant Sciences SHS (ROIV) | 0.2 | $1.7M | +8237% | 152k | 11.23 |
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $1.7M | 263k | 6.44 |
|
|
| Black Diamond Therapeutics (BDTX) | 0.1 | $1.6M | 556k | 2.81 |
|
|
| Rapt Therapeutics Put Option (RAPT) | 0.1 | $1.5M | NEW | 59k | 24.85 |
|
| Kodiak Sciences (KOD) | 0.1 | $1.3M | +31% | 413k | 3.04 |
|
| Acumen Pharmaceuticals (ABOS) | 0.1 | $1.2M | 315k | 3.84 |
|
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.1 | $1.2M | 196k | 6.04 |
|
|
| Coherus Biosciences (CHRS) | 0.1 | $1.1M | -60% | 341k | 3.33 |
|
| Inflarx Nv (IFRX) | 0.1 | $1.1M | 689k | 1.63 |
|
|
| Terns Pharmaceuticals (TERN) | 0.1 | $1.1M | 166k | 6.49 |
|
|
| Uniqure Nv SHS (QURE) | 0.1 | $1.1M | 157k | 6.77 |
|
|
| Esperion Therapeutics (ESPR) | 0.1 | $1.0M | -80% | 338k | 2.99 |
|
| Avrobio Ord (AVRO) | 0.1 | $977k | 718k | 1.36 |
|
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $936k | 473k | 1.98 |
|
|
| Kezar Life Sciences (KZR) | 0.1 | $809k | 853k | 0.95 |
|
|
| Milestone Pharmaceuticals (MIST) | 0.1 | $773k | 463k | 1.67 |
|
|
| Immunic Call Option (IMUX) | 0.1 | $675k | 450k | 1.50 |
|
|
| Tyra Biosciences (TYRA) | 0.1 | $667k | 48k | 13.85 |
|
|
| Allakos (ALLK) | 0.1 | $647k | -69% | 237k | 2.73 |
|
| Elevation Oncology (ELEV) | 0.1 | $629k | 1.2M | 0.54 |
|
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $592k | -89% | 15k | 40.76 |
|
| Verve Therapeutics Put Option (VERV) | 0.1 | $576k | +835% | 41k | 13.94 |
|
| Immatics SHS (IMTX) | 0.0 | $516k | 49k | 10.53 |
|
|
| Tracon Pharmaceuticals Com New (TCON) | 0.0 | $484k | 2.8M | 0.18 |
|
|
| Tempest Therapeutics (TPST) | 0.0 | $465k | NEW | 106k | 4.40 |
|
| Hookipa Pharma Inc equity (HOOK) | 0.0 | $430k | 531k | 0.81 |
|
|
| Anebulo Pharmaceuticals (ANEB) | 0.0 | $382k | 158k | 2.42 |
|
|
| Protara Therapeutics Com Stk (TARA) | 0.0 | $353k | 189k | 1.87 |
|
|
| Karyopharm Therapeutics (KPTI) | 0.0 | $346k | 400k | 0.86 |
|
|
| Verona Pharma Sponsored Ads (VRNA) | 0.0 | $257k | +15% | 368k | 0.70 |
|
| Relmada Therapeutics (RLMD) | 0.0 | $167k | 40k | 4.14 |
|
|
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.0 | $109k | 213k | 0.51 |
|
|
| Synlogic Com New (SYBX) | 0.0 | $79k | 20k | 3.85 |
|
|
| Stoke Therapeutics (STOK) | 0.0 | $64k | -3% | 12k | 5.26 |
|
| Annovis Bio Put Option (ANVS) | 0.0 | $64k | NEW | 3.4k | 18.70 |
|
| Finch Therapeutics Group Com New (FNCH) | 0.0 | $25k | 6.9k | 3.61 |
|
|
| Brainstorm Cell Therapeutics Com New (BCLI) | 0.0 | $25k | 90k | 0.27 |
|
|
| Aclaris Therapeutics (ACRS) | 0.0 | $21k | +103% | 20k | 1.05 |
|
| Ventyx Biosciences (VTYX) | 0.0 | $15k | +379% | 5.9k | 2.47 |
|
| Celldex Therapeutics Com New Put Option (CLDX) | 0.0 | $7.9k | -79% | 200.00 | 39.66 |
|
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.0 | $6.5k | 35k | 0.18 |
|
|
| Insmed Com Par $.01 Call Option (INSM) | 0.0 | $6.2k | -99% | 200.00 | 30.99 |
|
Past Filings by Ikarian Capital
SEC 13F filings are viewable for Ikarian Capital going back to 2019
- Ikarian Capital 2023 Q4 filed Feb. 14, 2024
- Ikarian Capital 2023 Q3 filed Nov. 14, 2023
- Ikarian Capital 2023 Q2 filed Aug. 14, 2023
- Ikarian Capital 2023 Q1 filed May 15, 2023
- Ikarian Capital 2022 Q4 filed Feb. 14, 2023
- Ikarian Capital 2022 Q3 filed Nov. 14, 2022
- Ikarian Capital 2022 Q2 filed Aug. 12, 2022
- Ikarian Capital 2022 Q1 filed May 13, 2022
- Ikarian Capital 2021 Q4 filed Feb. 14, 2022
- Ikarian Capital 2021 Q3 filed Nov. 15, 2021
- Ikarian Capital 2021 Q1 restated filed Aug. 18, 2021
- Ikarian Capital 2021 Q2 restated filed Aug. 18, 2021
- Ikarian Capital 2021 Q2 filed Aug. 16, 2021
- Ikarian Capital 2021 Q1 filed May 17, 2021
- Ikarian Capital 2020 Q4 filed Feb. 12, 2021
- Ikarian Capital 2020 Q3 filed Nov. 16, 2020